GMP and Research-grade Vector Production Facilities

Manufacturing Biotherapeutics to GMP standard for clinical trials can be one of the most difficult hurdles to overcome. Below are a number of facilities capable of manufacturing clinical and pre-clinical grade therapeutics including plasmid, oligonucleotides and viral vectors. There are also a selection of facilities capable of conducting the range of tests necessary to meet safety standards.

Aldevron Alembic Amsterdam Molecular Technologies
Angel Bio Avecia Biologics Avigen
Bio Products Laboratory Biogenova Bioprocessing Technology Institute
Bioreliance Ltd Biotec Distribution Wales Limited Boehringer Ingelheim RCV
Cancer Research UK CellGenix Celltec
Clinical Biomanufacturing Facility, Oxford Cobra Biomanufacturing Covance
Eden Biodesign Ltd Emergent Product Development UK Limited EUFETS AG
Eurogentec s.a. FinVectors Vision Therapies GeneArt/Genovac
Genethon Genethon Genzyme Limited
Henogen Henogen Introgen
Invitrogen/Bioreliance Lentigen Lonza Biologics
Microsafe BV Molmed NHSBT, Clinical Biotechnology Centre
Npil Pharmaceuticals (UK) Limited Omnia Biologics, Inc. PacificGMP
Plasmid Factory Polyplus-Transfection Powell Gene Therapy Centre, University of Florida
Protherics UK Limited Qbiogene Qiagen
Quintiles Limited Rentschler Biotechnologie Targeted Genetics
TBF Tissue Engineering  Texcell, a Pasteur Institute Co The Goldyne Saved Institute of Gene and therapy, Jerusalem, Israel

Ucb Celltech

Vector Biolabs

Vecura

VirXsys

Vivebiotech

 
icons

Registration for the 25th Anniversary Congress of the ESGCT is opening soon

Check our Berlin pages for more information, important dates and registration.